Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vaginal Atrophy × Dehydroepiandrosterone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaginal Atrophy 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Depression 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Atrophic Vaginitis 1 Anxiety Disorders 1

Interventions

Replens 1 Dehydroepiandrosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04493333 2024-11-27

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

University of Arkansas

Phase 2 Terminated

8 enrolled 11 charts

Vaginal Atrophy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡